Next |
home / stock / kzia / kzia message board
Subject | By | Source | When |
---|---|---|---|
Another one,Mr big shot, average price $1.05 sold | trendzone | investorshub | 11/01/2022 2:55:46 PM |
u sound angry....nice pick...lol | TrendTrade2016 | investorshub | 11/01/2022 2:22:28 PM |
What they really need to do is get | trendzone | investorshub | 10/27/2022 5:03:10 PM |
I'm in let. Goo positive | Pt3 | investorshub | 10/27/2022 12:25:24 PM |
KAZIA'S PAXALISIB DEMONSTRATES POSITIVE MONOTHERAPY EFFICACY SIGNALS IN | crudeoil24 | investorshub | 10/27/2022 12:19:57 PM |
They really need management like Dr. Kelly to | Xrouter | investorshub | 10/12/2022 2:04:39 AM |
What's the consensus on this one now? I | Cuppy | investorshub | 09/14/2022 3:55:50 PM |
Wow dump on news?? Makes no sense. | Roadtojourney | investorshub | 08/05/2022 2:51:42 PM |
Yessir brotha you're on FIRE>>>$$$$$$$$$$$$$$$$$$$$$$$$$$$ | doogdilinger | investorshub | 08/05/2022 2:19:00 PM |
Did you see that plow up for $3.37? | subslover | investorshub | 08/05/2022 2:08:36 PM |
KABOOM;) | doogdilinger | investorshub | 08/05/2022 2:05:01 PM |
Interim data from the first stage of the | subslover | investorshub | 08/05/2022 1:15:34 PM |
Kazia gains on FDAs rare pediatric disease designation | subslover | investorshub | 07/06/2022 12:35:29 PM |
My ask 10 where | Pt3 | investorshub | 06/17/2022 10:14:48 PM |
WOOHOOOOOO | weedtrader420 | investorshub | 06/17/2022 12:39:52 PM |
KZIA$ | weedtrader420 | investorshub | 06/17/2022 12:27:25 PM |
Absolutely! | Cuppy | investorshub | 03/11/2022 4:48:52 AM |
Bad timing. Looks like an easy 10 bagger | aussiekevin | investorshub | 03/26/2021 1:52:11 PM |
Patience is king. Im Out!!! Glad | ipo_dude | investorshub | 11/24/2020 6:08:31 PM |
Yes, the news was very negative so this | aussiekevin | investorshub | 11/20/2020 9:24:44 PM |
News, Short Squeeze, Breakout and More Instantly...
Kazia Therapeutics Limited Company Name:
KZIA Stock Symbol:
NASDAQ Market:
KAZIA REPORTS SUCCESSFUL STAGE 1 COMPLETION OF THE EVT801 PHASE 1 CLINICAL TRIAL IN ADVANCED CANCER PATIENTS PR Newswire SYDNEY , May 1, 2024 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), a biotechnology company specialising in oncology, is pleased t...
Shares of NextPlat Corp (NASDAQ: NXPL) rose sharply in today’s pre-market trading after the company reported consolidated 2023 revenues of $...
Shares of Byrna Technologies Inc. (NASDAQ: BYRN) rose sharply during Friday’s session after the company reported better-than-expected first-q...